Halozyme Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Halozyme Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Halozyme Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Halozyme Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Halozyme Therapeutics Inc (Halozyme) is a biopharmaceutical company that develops and markets novel recombinant human enzymes for enhancing biologics and drug delivery. Its proprietary technology platform: Enhanze, lead product: Hylenex recombinant, and focus on R&D activities are its strengths, even as overdependence on the US could be a cause for concern to the company. Halozyme could benefit from strategic agreements, the market potential of Alzheimer's disease, and regulatory approvals. However, dependence on third-party manufacturers, stringent government regulations, and intense competition could affect the company's business.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer